Influence of different kinds of valve types on clinical benefits of elderly patients with valvular heart disease
- VernacularTitle:不同瓣膜类型对老年瓣膜性心脏病患者临床获益的影响
- Author:
Fei ZHAO
1
,
2
;
Yang ZHOU
1
,
2
;
Shihai TANG
1
,
2
;
Bo ZHENG
1
,
2
;
Fan ZHANG
1
,
2
;
Wei LIU
1
,
2
;
Huali PENG
1
,
2
Author Information
1. Department of Thoracic and Cardiovascular Surgery, People'
2. s Hospital of Leshan City, Leshan, 614000, Sichuan, P.R.China
- Publication Type:Journal Article
- Keywords:
Mechanical valves;
biological valves;
old age;
valvular heart disease;
treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(07):762-765
- CountryChina
- Language:Chinese
-
Abstract:
Objective 聽 聽To investigate the influence of mechanical and biological valves on clinical benefits of elderly patients with valvular heart disease. Methods 聽 聽We retrospectively analyzed the clinical data of 280 elderly patients with valvular heart disease treated by valve replacement between 2008 and 2014 year. The patients were divided into two groups by tendency score matching including a group A with biological valves and a group B with mechanical valves. Finally, there were 96 patients in each group. There were 43 males and 53 females at age of 64.41卤6.52 years in the group A, 44 males and 52 females at age of 64.07卤6.20 years in the group B. Results 聽 聽The bleeding rate of skin and mucosa of the group B was significantly higher than that of the group A (P<0.05). There was no statistical difference in mortality within 30 days after operation, all-cause mortality, re-hospitalization rate, re-valve replacement rate, combined atrial flutter/atrial fibrillation ratio, drug use, incidence of cerebral infarction, cerebral hemorrhage, new peripheral vascular embolism and visceral hemorrhage, heart function (NYHA) classification, the cumulative survival rate of all the patients during follow-up (P=0.63), or the cumulative survival rate of the patients with no thrombus/hemorrhage (P=0.75) between the two groups (P>0.05). Conclusion 聽 聽Mechanical valve replacement and bioprosthetic valve replacement in the treatment of valvular heart disease in the elderly can achieve similar clinical benefits and both have clinical application value.
